Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31,20Y3 and 20Y2, is shown as follows: Total liabilities and stockholders' equity Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: a. The investments were sold for $143,100 cash. b. Equipment and land were acquired for cash. c. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a 575,480 credit to Retained Earnings for net income. f. There was a $49,130 debit to Retained Earnings for cash dividends declared. Changes in current operating assets and liabilities: Increase in accounts receivable Increase in inventories Increase in accounts payable Decrease in accrued expenses payable \begin{tabular}{|r|} \hline7,670 \\ \hline6,950 \\ \hline 9,560 \\ \hline5,750 \\ \hline \end{tabular} Cash flows from investing activities: Cash received from sale af investments Cash paid for purchase of land Cash paid far purchase af equipment $143,100165,50036,890 99,290 Net cash flow used for investing activities Cash flows from financing activities: Cash received from sale of comman stock Cash paid for dividends Net cash flow from financing activities Change in cash Cash at the end of the year